-
Virtual behavioral healthcare coordination company NeuroFlow secures $25M investment
NeuroFlow secured $25 million in growth capital for its platform for providers that streamlines the process of identifying, triaging and treating individuals with mental health issues. -
7 steps for mental health startups to rebuild trust
Digital mental health companies are struggling to rebuild trust with patients after a series of scandals. Cerebral was the subject of multiple federal probes from the Justice Department and Federal Trade Commission, whose investigation into possible overprescription of stimulants resulted in the replacement of its CEO. -
Phillips ambient behavioral health treatment rooms win award
Global health technology company Phillips earned a Touchstone Award from the Center for Health Design for its Ambient Experience behavioral health rooms. -
Alleva raises $12M to expand behavioral health EMR
Alleva's EMR software catered to behavioral health providers raised $12 million in series A funding. -
Mental health startup funding down in 2022 despite Alma's $130M megadeal
Digital health funding for mental health startups has dropped significantly this year, according to a quarterly report from Rock Health. -
Telehealth improves opioid use disorder treatment outcomes, data shows
The expansion of telehealth services for opioid use disorder treatment during the pandemic made treatment more accessible and lowered the likelihood of overdose, a study published Aug. 31 in JAMA Psychiatry found. -
Rightway debuts care navigation platform to simplify access to chronic care management, mental healthcare and more
Healthcare navigation platform company Rightway launched its partner program RightwayHub, a platform designed to make finding comprehensive care easier for members. -
Mental health app rolls out monitoring service to support physicians
Noble, a mental health app, launched a service designed to help physicians better treat and monitor patients who need support. -
Stress management device company secures $1M investment
Sensate raised more than $1 million in funding for its stress management device in an investment round. -
Startup's mental health-tracking ring nets $60M in funding
Tech startup Happy Health raised $60 million in funding for its ring designed to measure stress and mood. -
FDA-cleared 'prescription video game' startup nabs $163M investment
Digital medicine company Akili raised more than $163 million by combining with public trade acquisition company Capital Survetta Holdings. -
The mental health apps expected to drive 240% market growth by 2028
The mental health app market is projected to be valued at $9.9 billion by 2028, an increase of about 240 percent from 2021's value of $4.1 billion, according to a report by Vantage Market Research. -
It's time for behavioral health to adopt measurement, says CEO
Measurement-based care has been shown to produce better outcomes than usual standard care, which does not involve measurement. But multiple studies have shown a majority of behavioral health clinicians still do not use measurement-based care. -
HearMe, Ingenovis Health partner to provide nurses with 24/7 mental health support
Text-based mental health support provider HearMe and healthcare staffing firm Ingenovis Health partnered to create a free support system for travel nurses available 24/7. -
Mental health software market to reach $5.6B market value in 2028: 3 key factors driving growth
The mental health software market value is on track to reach $5.6 billion by 2028, led by three industry developments, according to a market research study published Aug. 8. by Facts and Factors. -
Abbott's breakthrough deep brain stimulation treatment: An overview
Abbott's deep brain stimulation device was awarded the FDA's breakthrough device designation for treatment-resistant depression, Abbott said July 27. -
UCLA psychiatrist Smitta Patel to join VyTrac Health's advisory board
Smitta Patel, MD, a psychiatrist at the UCLA Semel Institute for Neuroscience and Human Behavior, is joining VyTrac Health's medical advisory board. -
Neuronetics, Alleviant Health form exclusive partnership
Medical technology company Neuronetics will be the exclusive supplier of transcranial magnetic stimulation equipment used in the mental health treatment network of Arkansas-based Alleviant Health, Neuronetics said July 25. -
4 promising psychiatric medications seeking FDA approval
In clinical trials, four in-development psychiatric drugs show promise for treatment of schizophrenia, postpartum depression and major depressive disorder, MDLinx reported July 21. -
FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety
The FDA has approved Neuronetics' transcranial magnetic stimulation system as a treatment for adults with major depressive disorder, the company said this week.
Page 4 of 50